SAN FRANCISCO–(BUSINESS WIRE)–Tivic Well being® Methods, Inc. (“Tivic Well being”, Nasdaq: TIVC), a well being tech firm that develops and commercializes bioelectronic medication, is happy to announce the appointment of Lisa Wolf as Interim Chief Monetary Officer (CFO) of the corporate, efficient October 1, 2024. Ms. Wolf will take over from Kimberly Bambach, who has served as the corporate’s interim CFO since April 2023. Ms. Bambach will proceed with Tivic in an advisory function for strategic transactions
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/tivic-health-appoints-lisa-wolf-as-interim-chief-financial-officer/
